The BD FACSVerse™ flow cytometer was engineered from the ground up to offer remarkable performance, flexibility, and ease of operation for research applications using up to 10 parameters.
Citi analyst Joanne Wuensch reiterated a Buy rating on Becton Dickinson (BDX – Research Report) today. The company’s shares closed yesterday at $224.16. See what stocks are receiving Strong ...
In a report released today, Josh Jennings from TD Cowen maintained a Hold rating on Becton Dickinson (BDX – Research Report), with a price target of $260.00. The company’s shares closed last ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback